RK

Ramesh Kannabiran Arcot

Director DIN 03526302
DIN 03526302 First appointment May 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramesh Kannabiran Arcot

Data last updated:

Ramesh Kannabiran Arcot was a Director at Dharmavarapu Biotech Private Limited (from 2010) and Director at Shri Danishta Milk And Agros Private Limited (from 2011).

DIN 03526302
First Appointment 19 May 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dharmavarapu Biotech Private Limited U24232TG2010PTC068336
Director19 May 20102010Strike Off
Director10 Jun 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dharmavarapu Biotech Private Limited
Shri Danishta Milk And Agros Private Limited
Premium access

Shareholding and investment profile for Ramesh Kannabiran Arcot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Kannabiran Arcot

Ramesh Kannabiran Arcot was first appointed on 19 May 2010 as Director at Dharmavarapu Biotech Private Limited. The most recent appointment on record is 10 Jun 2011 at Shri Danishta Milk And Agros Private Limited.

Ramesh Kannabiran Arcot held 2 earlier board appointments: Dharmavarapu Biotech Private Limited (Director, from 19 May 2010); Shri Danishta Milk And Agros Private Limited (Director, from 10 Jun 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available